Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page
- CheckyesterdayChange DetectedFooter updates: the page now displays 'Revision: v3.3.3' and the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' mention were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe revision label changed from v3.2.0 to v3.3.2, with no other changes to trial details or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe government funding status notice/banner was removed from the page. This does not affect the study data or enrollment details.SummaryDifference0.4%

- Check51 days agoChange DetectedNew screenshot shows a UI redesign with updated layout and visuals, while all trial data (outcome measures, eligibility criteria, study dates, and recruitment status) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a government-status notice and version v3.2.0; removed the previous version v3.1.0.SummaryDifference7%

- Check87 days agoChange DetectedVersion tag updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.